ENDRA Life Sciences Inc. — Director's Dealing 2020

Jan 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2020-01-25

Reporting Person: Maloberti Renaud Bertrand (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-25	Stock Options	$1.71	A	20000	Acquired	2030-01-25	Common Stock (20000)	Direct

Footnotes

F1: This stock option grant becomes exercisable in three equal annual installments beginning January 25, 2021.